DCWT(03768) recommends appointing Mu Yong as an executive director.
Dianchi Water Affairs (03768) has announced that Mr. Zeng Feng, an executive director of the company, is reaching the statutory retirement age and intends to resign from the positions of executive director, chairman of the board, chairman of the strategic and investment decision-making committee, member of the nomination committee, and member of the remuneration and assessment committee. His resignation will take effect on the day his formal resignation letter is submitted to the board of directors. Before his resignation takes effect, Mr. Zeng will continue to fulfill his duties and responsibilities as executive director, chairman of the board, chairman of the strategic and investment decision-making committee, member of the nomination committee, and member of the remuneration and assessment committee.
DCWT (03768) issued an announcement that Mr. Zeng Feng, an executive director of the company, is reaching the statutory retirement age and intends to resign from his positions as executive director, chairman of the board, chairman of the strategic and investment decision-making committee, member of the nomination committee, and member of the remuneration and appraisal committee. His resignation will take effect on the date when his written resignation is formally submitted to the board. Until his resignation takes effect, Mr. Zeng will continue to fulfill his duties and responsibilities related to his positions.
At the 266th meeting of the first board of directors of the company held on April 10, 2026, it was proposed and approved to appoint Mr. Mu Yong as an executive director of the first board of directors of the company. The proposal to appoint Mr. Mu as an executive director of the company will be submitted as a resolution at an extraordinary general meeting of the company for the shareholders' consideration and approval.
Related Articles

BEAUTYFARM MED(02373) spent 1.2129 million Hong Kong dollars to repurchase 60,000 shares on April 10th.

GAUSH MEDITECH (02407): Gaush Innovation Receives CE Certificate for Corneal Confocal Microscope.

HANXBIO-B (03378) spent HK$602,600 on April 10 to repurchase 20,000 shares.
BEAUTYFARM MED(02373) spent 1.2129 million Hong Kong dollars to repurchase 60,000 shares on April 10th.

GAUSH MEDITECH (02407): Gaush Innovation Receives CE Certificate for Corneal Confocal Microscope.

HANXBIO-B (03378) spent HK$602,600 on April 10 to repurchase 20,000 shares.

RECOMMEND





